---
title: "Taiyo Kosan Amends Tender Offer for Hisamitsu Pharmaceutical"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/274622743.md"
datetime: "2026-02-03T08:34:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274622743.md)
  - [en](https://longbridge.com/en/news/274622743.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274622743.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/274622743.md) | [English](https://longbridge.com/en/news/274622743.md)


# Taiyo Kosan Amends Tender Offer for Hisamitsu Pharmaceutical

TAIYO KOSAN CO., INC. has filed an amendment to its previously announced tender offer for the common stocks, share acquisition rights, and depository receipts for share certificates of Hisamitsu Pharmaceutical Co., Inc. The amendment updates the contents of the initial public notice of commencement of the tender offer, reflecting changes detailed in the latest filing. TAIYO KOSAN CO., INC. disclosed that these updates were made in connection with the amended tender offer registration statement submitted on February 3, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hisamitsu Pharmaceutical Co. Ltd. published the original content used to generate this news brief on February 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相關股票

- [Takeda Pharmaceutical Co. Ltd. (4502.JP)](https://longbridge.com/zh-HK/quote/4502.JP.md)
- [Hisamitsu Pharmaceutical Co., Inc. (4530.JP)](https://longbridge.com/zh-HK/quote/4530.JP.md)

## 相關資訊與研究

- [Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda](https://longbridge.com/zh-HK/news/281408915.md)
- [Takeda's Zasocitinib Shows Rapid, Durable Skin Clearance In Phase 3 Psoriasis Trials](https://longbridge.com/zh-HK/news/280914764.md)
- [Tranche Update on Ebara Corporation's Equity Buyback Plan announced on February 13, 2026.](https://longbridge.com/zh-HK/news/281422680.md)
- [Ibiden Co.,Ltd.(TSE:4062) added to S&P TOPIX](https://longbridge.com/zh-HK/news/280996796.md)
- [Shiseido Company, Limited Announces Directorate Appointments](https://longbridge.com/zh-HK/news/280766447.md)